IP Library Granted Patent US 9,205,053
Granted Patent B2
US 9,205,053 · App. 12/534,070 · Granted Dec 8, 2015

Injectable microspheres for dermal augmentation and tissue bulking

Inventors: Jean-Marie Vogel (Lincoln, MA); Richard Thomas (Lincoln, MA); Egisto Boschetti (Croissy-sur-Seine, FR)
Assignee: Biosphere Medical, Inc.
A61K9/14A61K9/0019A61K9/1635A61K9/1641A61K31/78A61K31/785A61K47/48869A61K47/48876A61K49/048A61K49/0442A61L27/38A61L27/50A61L31/005A61L31/14A61K9/16A61L2400/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,205,053
App. No.
12/534,070
Granted
Dec 8, 2015
Kind
B2
Abstract

The present invention relates to elastic, hydrophilic and substantially spherical microspheres useful for dermal augmentation and tissue bulking. The invention provides injectable compositions comprising the microspheres and a biocompatible carrier for use in dermal augmentation. The present invention further provides methods of dermal augmentation and tissue bulking, particularly for the treatment of skin contour deficiencies, Gastro-esophageal reflux disease, urinary incontinence, and urinary reflux disease, using the injectable compositions.

Claims (15)

1. A method for dermal augmentation in a mammal comprising injecting a composition of non-biodegradable, elastic, hydrophilic, non-toxic and substantially spherical microspheres having a diameter of from about 10 μm to about 400 μm in a biocompatible carrier to said mammal through a needle of about 30 gauge or smaller, wherein the microspheres comprise one or more of: acrylamide polymers, vinyl alcohol polymers, or derivatives and mixtures thereof.

2. The method of claim 1 , wherein the composition is a suspension of said microspheres in said biocompatible carrier.

3. The method of claim 1 , wherein there is no aggregation or clumping of the microspheres prior to or during the administration.

4. The method of claim 1 , wherein the composition further comprises a therapeutic agent, radio-pacifying agent, contrast media, or mixtures thereof.

5. The method of claim 4 , wherein said therapeutic agent is bound to the microspheres.

6. The method of claim 1 , wherein the microspheres are capable of being chemically modified to have therapeutic effects, anti-inflammatory effects, anti-bacterial effects, anti-histamine effects, or combinations thereof.

7. The method of claim 6 , wherein the chemical modification of the microspheres is caused by interactions between the microspheres and neighboring tissues after administration thereof.

8. The method of claim 1 , wherein the administration comprises injecting said composition into an area of said mammal in need of dermal augmentation.

9. The method of claim 8 , wherein the administration comprises injecting said composition into the subcutaneous layer.

10. The method of claim 1 , wherein the dermal augmentation is for treatment of contour deficiencies of said mammal.

11. The method of claim 10 , wherein the contour deficiencies are caused by aging, environmental exposure, weight loss, child bearing, surgery, disease, or combinations thereof.

12. The method of claim 11 , wherein the disease is acne, skin cancer, or combination thereof.

13. The method of claim 11 , wherein the contour deficiencies are one or more of the group consisting of frown lines, worry lines, wrinkles, crow's feet, marionette lines, stretch marks, and internal or external scars resulted from injury, wound, surgery, bites, cuts, or accident.

14. The method of claim 1 , wherein the mammal is human.

15. The method of claim 1 , wherein the administration comprises injecting said composition extracorporeally into organs, components of organs, or tissues prior to their inclusion into said mammal's body, organs, or components of organs.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Jan 25, 2013
From: BIOSPHERE MEDICAL, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 029698/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2010
From: VOGEL, JEAN-MARIE; THOMAS, RICHARD; BOSCHETTI, EGISTO
To: BIOSPHERE MEDICAL, INC.
Reel/Frame 023943/0085 →
Continuity (5)
Continuation 10704919 · Nov 12, 2003
Continuation 09528991 · Mar 20, 2000
Continuation In Part 09263773 · Mar 5, 1999
Provisional Application 60077166 · Mar 6, 1998
Related Publication 20110033508A1 · Feb 10, 2011